NCT00266279 2020-09-03
Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies
University of Louisville
Phase 2 Completed
Clinical Trials
4 trialsNCT00591149 2017-06-14
Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer
University of Kansas Medical Center
Phase 2 Terminated
NCT00256295 2017-02-01
Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer
University of California, Irvine
Phase 2 Terminated
NCT00503997 2012-05-10
Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
Phase 2 Completed